Physician profile
Michael E Keelan
NPI 1316026933
$4,757.89
in general payments reported to CMS, 2019-2025
41 companies · $659 in 2025
The $659 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $797 · 2020: $658 · 2021: $790 · 2022: $784 · 2023: $743 · 2024: $327 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,729.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $649.92 | 2019-2025 | |
| Abbvie INC. | $594.05 | 2019-2023 | |
| Exeltis, USA INC. | $289.84 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $284.14 | 2020-2023 | Injectafer |
| Mayne Pharma Commercial LLC | $283.89 | 2022-2025 | |
| Hologic Sales and Service, LLC | $282.38 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Novasure |
| Radius Health, INC. | $259.94 | 2019-2025 | |
| Medtronic, INC. | $187.84 | 2022-2023 | Truclear, Interstim |
| Astellas Pharma US INC | $181.96 | 2019-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $166.36 | 2020-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $162.72 | 2019-2022 | |
| Pfizer INC. | $141.92 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $140.65 | 2023-2025 | Myfembree |
| Millicent US INC | $110.10 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Coopersurgical, INC. | $90.78 | 2019-2023 | Paragard T 380a |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $85.71 | 2022-2025 | Nexplanon |
| Amgen INC. | $83.70 | 2019-2024 | Evenity, Prolia |
| Lupin INC. | $75.39 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $71.87 | 2019 | |
| Exact Sciences Corporation | $68.35 | 2023-2025 | Cologuard Collection Kit |
| Smith+Nephew, INC. | $66.00 | 2019 | |
| Avion Pharmaceuticals | $57.95 | 2019-2021 | |
| Agile Therapeutics, INC. | $51.30 | 2021-2022 | |
| Allergan, INC. | $38.68 | 2019 | |
| Shield Therapeutics INC | $29.15 | 2025 | |
| Amag Pharmaceuticals, INC. | $26.86 | 2019 | |
| Scynexis, INC. | $26.28 | 2021-2022 | |
| Alydia Health | $25.81 | 2021 | |
| Myovant Sciences INC. | $25.77 | 2021-2022 | |
| Roche Diagnostics Corporation | $22.90 | 2021 | |
| Davol INC. | $20.77 | 2020 | |
| Duchesnay USA Incorporated | $20.46 | 2019 | |
| Optumhealth Care Solutions, LLC | $18.58 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Covidien LP | $17.13 | 2020 | |
| Aspira Women'S Health INC | $15.26 | 2023 | Ova1 |
| Almatica Pharma LLC | $15.11 | 2025 | Teriparatide |
| Mylan Pharmaceuticals INC. | $15.00 | 2021 | |
| Merck Sharp & Dohme LLC | $14.77 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.01 | 2025 | Exparel |
| Mimedx Group, INC. | $13.45 | 2024 | |
| Dysis Medical, INC. | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Keelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.